文献速递运动医学创伤骨科

连续股神经阻滞用于前交叉韧带重建后股神经功能的电生理研究:随机对照单盲试验

Electrophysiological Study of Femoral Nerve Function After a Continuous Femoral Nerve Block for Anterior Cruciate Ligament Reconstruction: A Randomized, Controlled Single-Blind Trial.
PubMed 文献 · Am J Sports Med · 2016-11-13

该随机对照单盲试验将74例前交叉韧带重建患者随机分为连续股神经阻滞(CFNB)组和静脉吗啡患者自控镇痛(IV PCA)组,主要结局为术后4周股神经损伤的电生理标准。结果显示无患者符合股神经损伤的电生理标准,两组在功能结局和疼痛评分上无差异,但CFNB组在恢复第1阶段及术后第1、2天的静脉吗啡等效消耗量均低于IV PCA组。

要点

  • CFNB组与IV PCA组均无患者符合股神经损伤的电生理标准。
  • 术后4周平均复合肌肉动作电位(CMAP)面积两组等效。
  • CFNB组在恢复第1阶段及术后第1、2天的静脉吗啡等效消耗量低于IV PCA组。

核心结论

  • 尽管先前有相反报道,CFNB并未导致前交叉韧带重建后的股神经损伤或功能结局恶化。
  • CFNB的镇痛改善仅 marginal,且在24小时后无临床相关性。

研究设计与样本

  • 随机对照临床试验,证据等级1。
  • 共74例计划行前交叉韧带重建的患者随机接受CFNB(术前,随后罗哌卡因输注2天及羟考酮)或IV PCA。

主要发现

  • 无患者符合股神经损伤的电生理标准。
  • 术后4周平均CMAP面积在CFNB组和IV PCA组等效(47 ± 16 mV·ms 和 51 ± 13 mV·ms,P = .50)。
  • 功能结局或疼痛评分未检测到差异。
  • 与IV PCA相比,CFNB组在恢复第1阶段的静脉吗啡等效消耗量减少(6 ± 5 mg 和 13 ± 7 mg,P = .0003),术后第1天减少(6 ± 7 mg 和 19 ± 17 mg,P = .0005),术后第2天减少(11 ± 10 mg 和 19 ± 17 mg,P = .03)。

关键数值与推荐

  • 主要结局为术后4周股神经损伤率,定义为腹股沟处超强股神经刺激后股内侧肌复合肌肉动作电位(CMAP)面积降低,伴股神经H反射消失和股内侧肌去神经支配征象。
  • 次要功能结局为术后第1天和第2天测量的股四头肌肌力、主动屈曲范围和步行距离。
  • 次要疼痛相关结局为恢复第1阶段及术后第1天和第2天的静脉吗啡消耗量和静息及运动时疼痛评分。

临床怎么用

  • 原文未据此给出推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A continuous femoral nerve block (CFNB) is an effective analgesic treatment after anterior cruciate ligament (ACL) reconstruction but may result in transient femoral nerve injuries and quadriceps muscle weakness, which in turn contribute to worsened functional outcomes. PURPOSE: To compare electrophysiological criteria of a femoral nerve injury as well as functional and pain-related outcomes after ACL reconstruction when analgesia was provided by a CFNB or intravenous patient-controlled analgesic of morphine (IV PCA). STUDY DESIGN: Randomized controlled clinical trial; Level of evidence, 1. METHODS: A total of 74 patients scheduled for ACL reconstruction were randomized to receive a CFNB before surgery, followed by a ropivacaine infusion for 2 days and oxycodone, or IV PCA. The primary outcome was the rate of femoral nerve injuries at 4 weeks postoperatively, defined as a reduction of the compound muscle action potential (CMAP) area from the vastus medialis muscle after supramaximal femoral nerve stimulation at the groin, associated with an absent H-reflex of the femoral nerve and signs of vastus medialis muscle denervation. Secondary functional outcomes were quadriceps muscle strength, active flexion range, and distance walked, as measured on postoperative days 1 and 2. Secondary pain-related outcomes were IV morphine consumption and pain scores at rest and on movement in phase 1 recovery and on postoperative days 1 and 2. RESULTS: No patients met the electrophysiological criteria of a femoral nerve injury. The mean CMAP area at 4 weeks was equivalent in both the CFNB and IV PCA groups (47 ± 16 mV·ms and 51 ± 13 mV·ms, respectively; P = .50). While no differences were detected in functional outcomes or pain scores, the consumption of an IV morphine equivalent was reduced by the administration of a CFNB in phase 1 recovery (6 ± 5 mg and 13 ± 7 mg, respectively; P = .0003), on postoperative day 1 (6 ± 7 mg and 19 ± 17 mg, respectively; P = .0005), and on postoperative day 2 (11 ± 10 mg and 19 ± 17 mg, respectively; P = .03) compared with an IV PCA. CONCLUSION: Despite prior contrary reports, a CFNB did not result in femoral nerve injuries or worsened functional outcomes after ACL reconstruction. The improvement of analgesia with a CFNB was only marginal and not clinically relevant beyond 24 hours. Registration: NCT01321138 ( ClinicalTrials.gov identifier).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Stebler K, Martin R, Kirkham KR, et al. Electrophysiological Study of Femoral Nerve Function After a Continuous Femoral Nerve Block for Anterior Cruciate Ligament Reconstruction: A Randomized, Controlled Single-Blind Trial. Am J Sports Med. 2016. PMID: 27836905. doi:10.1177/0363546516669715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。